10 completed, 7 terminated, 5 not yet recruiting, 4 active not recruiting. 13 Phase 1, 13 Phase 2, 3 Phase 3, 2 Not applicable.
Follow Peritoneal Carcinoma: new trials by email Literature Review of Peritoneal Carcinoma trials Research Report on Peritoneal Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Supplemental Arginine With Chemotherapy and Immunotherapy in Platinum Resistant Ovarian, Fallopian Tube, and Peritoneal Cancer (Arginaid®) Oral Arginine, (R-Gene® 10) IV Arginine, Pembrolizumab - Platinum Resistant Ovarian Cancer, Fallopian Tube Cancers | Phase 1 | Not yet recruiting | Rebecca Arend | 24 | 2026-09-01 | 2026-10-15 |
| Paricalcitol Versus Pirfenidone for Improving Surgical Resectability in Patients With Peritoneal Cancer Paricalcitol, pirfenidone - Peritoneal (Metastatic) Cancer, Peritoneal Carcinoma | Phase 2 | Not yet recruiting | Patrick Wagner, MD, FACS | 74 | 2026-09-01 | 2026-10-05 |
| SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer SCT-001 CAR-T cells - Ovarian Cancer, Fallopian Tube Carcinoma | Phase 1 | Not yet recruiting | Shanghai Gynecologic Oncology Group | 24 | 2025-06-01 | 2025-02-26 |
| Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors vvDD-hIL-2-RG-1 - Gastric Neoplasms, Esophageal Cancer | Phase 1 | Recruiting | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 18 | 2025-05-06 | 2025-06-03 |
| Study and Modulation of Immune Responses in Primary and Metastatic Colon Cancers Sampling - Colon Cancer, Peritoneal Carcinoma | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 500 | 2024-06-15 | 2024-05-30 | |
| International Registration of Isolated STIC: to Report and Investigate the Risk of Serous Peritoneal Carcinomatosis No intervention, only registration - BRCA Mutation, Serous Tubal Intraepithelial Carcinoma | Not yet recruiting | Radboud University Medical Center | 600 | 2024-06-01 | 2024-05-01 | |
| NM32-2668 in Adult Patients With Selected Advanced Solid Tumors NM32-2668 - Ovarian Carcinoma, Fallopian Tube Carcinoma | Phase 1 | Terminated | Numab Therapeutics AG | 11 | 2024-05-01 | 2025-07-23 |
| Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery Acute Normovolemic Hemodilution/ANH - Ovarian Cancer, Fallopian Tube Carcinoma | Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | 86 | 2024-02-23 | 2026-04-01 |
| Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy AHCC, Chemotherapy, Placebo - Ovarian Epithelial Carcinoma, Fallopian Tube Carcinoma | Phase 2 | Active not recruiting | University of California, Davis | 20 | 2023-08-01 | 2026-03-12 |
| Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Oregovomab, Paclitaxel, Carboplatin - Ovarian Neoplasm Epithelial, Ovarian Cancer | Phase 2 | Active not recruiting | CanariaBio Inc. | 88 | 2023-02-07 | 2026-10-23 |
| Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators COLLAT-COVID is an observational study based on retrospective data issued from patients medial files. - Hepatocellular Carcinoma, Peritoneal Carcinoma | Unknown | Hospices Civils de Lyon | 4000 | 2022-12-01 | 2023-07-10 | |
| DCVAC/OvCa and Standard of Care (SoC) in Relapsed Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma DCVAC/OvCa, DCVAC/OvCa placebo - Ovarian Cancer, Fallopian Tube Cancer | Phase 3 | Withdrawn | SOTIO a.s. | 2021-08-01 | 2021-12-23 | |
| Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy Second look laparoscopy reassessment surgery (SLLRS), HIPEC with Carboplatin, FACT-O Quality of Life Questionnaire - Ovarian Epithelial Cancer Stage I, Ovarian Epithelial Cancer Stage II | Phase 2 | Completed | Wake Forest University Health Sciences | 10 | 2021-05-20 | 2026-08-10 |
| Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal Cancer Oxaliplatin, mFOLFIRI - Colorectal Cancer, Appendiceal Cancer | Phase 1 | Terminated | University of Utah | 1 | 2021-03-22 | 2021-09-27 |
| Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery Oregovomab, Paclitaxel, Carboplatin - Carcinoma, Ovarian Epithelial, Ovarian Neoplasms | Phase 3 | Active not recruiting | CanariaBio Inc. | 615 | 2020-08-25 | 2026-04-01 |
| A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors NM21-1480 - Advanced Solid Tumor, Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Terminated | Numab Therapeutics AG | 52 | 2020-08-19 | 2025-05-23 |
| Study of Radspherin® in Colorectal Carcinoma Subjects With Peritoneal Carcinomatosis Treated With HIPEC Radspherin - Peritoneal Carcinoma, Colorectal Carcinoma | Phase 1 / Phase 2 | Completed | Oncoinvent Solutions AS | 47 | 2020-05-27 | 2025-08-28 |
| A Trial Evaluating TG4050 in Ovarian Carcinoma. TG4050 - Ovarian Carcinoma, Fallopian Tube Cancer | Phase 1 | Completed | Transgene | 64 | 2019-12-09 | 2025-11-14 |
| A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum 131 I-omburtamab, WAP-IMRT - Desmoplastic Small Round Cell Tumor, Peritoneal Cancer | Phase 2 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 31 | 2019-07-15 | 2026-07-21 |
| Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy Hysteroscopic cell sampling of the fallopian tube - Fallopian Tube Cancer, Ovarian Cancer | Completed | Boston Scientific Corporation | 150 | 2018-08-27 | 2021-01-20 |
Showing 20 of 33. Sign in to see all of them.
Fallopian Tube Neoplasms (22) · Ovarian Neoplasms (20) · Carcinoma, Ovarian Epithelial (5) · Neoplasms (4) · Colorectal Neoplasms (3) · Peritoneal Neoplasms (3) · Adenocarcinoma of Lung (2) · Carcinoma (2) · Mesothelioma, Malignant (2) · Neoplasm Metastasis (2) · Triple Negative Breast Neoplasms (2) · Appendiceal Neoplasms (1) · COVID-19 (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1)
Neoplasms by Site (32) · Neoplasms (29) · Adnexal Diseases (26) · Female Urogenital Diseases (26) · Female Urogenital Diseases and Pregnancy Complications (26) · Genital Diseases (26) · Genital Diseases, Female (26) · Genital Neoplasms, Female (26) · Urogenital Diseases (26) · Urogenital Neoplasms (26) · Endocrine Gland Neoplasms (24) · Endocrine System Diseases (24) · Gonadal Disorders (24) · Ovarian Diseases (23) · Fallopian Tube Diseases (22)
Carboplatin (9) · Paclitaxel (5) · Bevacizumab (2) · Hyperthermic Intraperitoneal Chemotherapy (2) · Oxaliplatin (2) · Platinum (2) · liposomal doxorubicin (2) · oregovomab (2) · Anastrozole (1) · Arginine (1) · Cisplatin (1) · Cyclophosphamide (1) · Cytoreduction Surgical Procedures (1) · Diagnostic Imaging (1) · Dimethoate (1)
CanariaBio Inc. (2) · Hospices Civils de Lyon (2) · Memorial Sloan Kettering Cancer Center (2) · Numab Therapeutics AG (2) · Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) (1) · Assistance Publique - Hôpitaux de Paris (1) · Boston Scientific Corporation (1) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (1) · InterMune (1) · Masonic Cancer Center, University of Minnesota (1) · Massachusetts General Hospital (1) · National Cheng-Kung University Hospital (1) · Oncoinvent Solutions AS (1) · Patrick Wagner, MD, FACS (1) · Radboud University Medical Center (1)
United States (20) · France (4) · India (2) · Italy (2) · Spain (2) · Taiwan (2) · Argentina (1) · Belgium (1) · Brazil (1) · Canada (1) · Chile (1) · China (1) · Czechia (1) · Finland (1) · Hungary (1)
Akira Hirasawa, M.D., Ph.D. (1) · Carolyn Krasner, MD (1) · Claudio Zamagni, MD (1) · David Cibula, Prof. MD PhD (1) · Dennis Chi, MD (1) · Emily Slotkin, MD (1) · Harald Fricke, MD PhD (1) · Hui Chen, MD (1) · Jada Srinivasa Rao, PhD (1) · Janos L Tanyi, MD, PhD (1) · Jordan Waypa, FNP (1) · Krishnansu Tewari, MD (1) · Lan G Coffman, M.D. (1) · Laura Lambert, MD (1)
PMID 31179244, PMID 35972817, PMID 36936230, PMID 41424175
2018 (1), P30CA012197 (1)